Effects of alpha‐interferon on theophylline pharmacokinetics and metabolism.
- 1 June 1989
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 27 (6) , 795-802
- https://doi.org/10.1111/j.1365-2125.1989.tb03442.x
Abstract
1. The influence of alpha‐interferon (Roferon‐A) on the pharmacokinetics and metabolism of theophylline was studied in healthy adults. Roferon‐A was administered as an intra‐muscular injection (3 x 10(6) iu) once‐a‐day over 3 days. One week prior to and immediately after this course a single 20 min aminophylline infusion (4 mg kg‐1) was given. 2. Blood samples for theophylline analysis were taken over 48 h. Urine was collected up to 72 h and assayed for theophylline and its major metabolites 3‐methylxanthine, 1,3‐dimethyluric acid and 1‐ methyluric acid. 3. Pharmacokinetic parameters for theophylline in plasma were calculated. From urinary excretion data the overall metabolic clearance of theophylline and clearances for formation of the metabolites were calculated. 4. After interferon administration, there was a significant increase of approximately 15% in the mean values of the terminal elimination half‐life, area under the curve and mean residence time of theophylline in association with a similar decrease in plasma clearance (P less than 0.05). Formation clearances of the metabolites tended to be smaller after treatment, but only the change in the overall clearance of theophylline was significantly different (P less than 0.05). There was no systematic shift in the metabolic pattern of theophylline. 5. Additional investigations of the influence of the duration of alpha‐interferon treatment are necessary before definite conclusions can be drawn about the mechanism and the clinical relevance of the described interaction.This publication has 30 references indexed in Scilit:
- No Effect of Influenza Vaccination on Theophylline Pharmacokinetics as Studied by Ultraviolet Spectrophotometry, HPLC, and EMIT Assay MethodsTherapeutic Drug Monitoring, 1988
- INHIBITION OF THEOPHYLLINE METABOLISM BY INTERFERONThe Lancet, 1987
- Therapeutic consequences of drug interactions with theophylline pharmacokineticsJournal of Allergy and Clinical Immunology, 1986
- Decreased Theophylline Clearance Causing Toxicity in Children during Viral EpidemicsJournal of Asthma, 1985
- Theophylline Pooled Michaelis-Menten Parameters (Vmax and Km) and ImplicationsClinical Pharmacokinetics, 1985
- Pharmacokinetic Drug Interactions with TheophyllineClinical Pharmacokinetics, 1984
- Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivoXenobiotica, 1983
- The application of statistical moment theory to the evaluation ofin vivo dissolution time and absorption timeJournal of Pharmacokinetics and Biopharmaceutics, 1980
- THEOPHYLLINE PHARMACOKINETICS DURING RESPIRATORY VIRAL INFECTIONThe Lancet, 1979
- ALTERED THEOPHYLLINE PHARMACOKINETICS DURING ACUTE RESPIRATORY VIRAL ILLNESSThe Lancet, 1978